Medical News

RSS

Biogen Idec acquires Neurimmune subsidiary

Biogen Idec and Neurimmune Holding AG today announced that Biogen Idec has acquired a subsidiary of Neurimmune, which includes the world-wide rights to three pre-clinical immunotherapy programs. The three programs are focused on the discovery and development of novel human antibodies that address three central nervous system (CNS) targets: alpha-synuclein, tau and TDP-43.

21 Dec 2010

American Surgical to be acquired by AH Holdings

American Surgical Holdings, Inc. announced today that it has entered into a definitive merger agreement pursuant to which American Surgical will be acquired and taken private by AH Holdings Inc., an affiliate of Great Point Partners, I LP ("GPP"), a Greenwich, CT-based private equity fund.

21 Dec 2010

Treatment with acid-suppressive drugs associated with increased risk of pneumonia

Using acid suppressive medications, such as proton pump inhibitors and histamine2 receptor antagonists, may increase the risk of developing pneumonia, states an article in CMAJ (Canadian Medical Association Journal).

21 Dec 2010

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Although the incidence of malaria has declined in all but a few countries worldwide, according to a World Health Organization report earlier this month, malaria remains a global threat. Nearly 800,000 people succumbed to the mosquito-borne disease in 2009, nearly all of them in the developing world.

21 Dec 2010

Echinacea may have minimal impact in relieving common cold

An over-the-counter herbal treatment believed to have medicinal benefits has minimal impact in relieving the common cold, according to research by the University of Wisconsin-Madison School of Medicine and Public Health.

21 Dec 2010

Study reveals nasal congestion can be a sign of severe asthma

Nasal congestion can be a sign of severe asthma, which means that healthcare professionals should be extra vigilant when it comes to nasal complaints. Furthermore, more severe asthma appears to be more common than previously thought, reveals a study from the Sahlgrenska Academy's Krefting Research Centre.

21 Dec 2010

PharMEDium introduces pre-labeled, ready-to-use Propofol in tamper evident syringe admixture system

PharMEDium Services LLC, announced the addition of Propofol to its custom operating room anesthesia syringe preparation services. PharMEDium is the first compounder to offer Propofol in a pre-labeled, single patient, ready-to-use, tamper evident syringe admixture system. Healthcare organizations recognize benefits of PharMEDium's prefilled operating room syringes including compliance with regulatory requirements for proper labeling of all medications, and improved economic efficiency by reducing waste.

21 Dec 2010

New study finds racial, ethnic disparities in cancer treatment

Black people with early stage liver cancer were more likely than white patients to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center.

21 Dec 2010

Early life food influences life-long fertility

The reproductive success of men and women is influenced by the food they receive at an early stage in life, according to new research by the University of Sheffield.

21 Dec 2010

Wage growth slowed during economic downturn, report says

The global economic downturn caused the growth in wages worldwide to be halved in 2008 and 2009, according to the International Labour Organisation's (ILO) recent Global Wage Report, Agence France-Presse reports (12/16).

21 Dec 2010

Hemispherx to manufacture and supply Alferon N Injection to GP Pharm in Argentina

Hemispherx Biopharma, Inc. announced that the Company has entered into an agreement with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA for the marketing of Alferon N Injection®, the Company's natural interferon injection product which has been FDA approved for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries upon receipt of those respective countries' regulatory approval for any use of the product.

21 Dec 2010

Exome sequencing leads to correct diagnosis and life-saving treatment for mysterious genetic disorder

A genetic testing approach called exome sequencing—which provides a clinically practical alternative to whole-genome sequencing—led to correct diagnosis and life-saving treatment in a child with a previously unknown genetic disease, reports an upcoming paper in Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics (ACMG). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

21 Dec 2010

Robotic surgery as effective as other minimally invasive techniques for head and neck squamous cell carcinomas

Less-invasive robotic surgery for upper airway and digestive track malignant tumors is as effective as other minimally invasive surgical techniques based on patient function and survival, according to University of Alabama at Birmingham researchers.

21 Dec 2010

Hutchinson Center's tips for weight loss in the new year

Losing weight is at the top of many a New Year's resolution list. In addition to maintaining a healthy diet and getting enough exercise, what else can one do to make sure those good intentions have a lasting impact throughout the year?

21 Dec 2010

Veeva announces seamless integration of CRM solution with Mederi

Veeva Systems, the global leader in cloud CRM solutions for the life sciences industry announces the ability to integrate with Mederi, a leading provider of network intelligence and insights for the healthcare industry. The seamless integration between Veeva CRM and Mederi allows pharmaceutical companies to manage their customer relationships and to analyse professional networks within one application, ensuring a much more coordinated and effective interaction with key stakeholders.

20 Dec 2010

Ambit commences Phase I advanced solid tumor trials for AC430 and AC480 inhibitors

Ambit Biosciences, today announced that it has initiated separate Phase I trials for two products AC430, a selective Janus Kinase 2 (JAK2) inhibitor, and AC480, a pan-HER inhibitor.

20 Dec 2010

Health-care coverage program for kids ends in Ariz.; Florida Medicaid patient information may be at risk

A new audit criticizes the Florida Agency for Health Care Administration and a contractor for failing to properly control access to computer systems that include sensitive information about Medicaid beneficiaries (Saunders, 12/17).

20 Dec 2010

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.

20 Dec 2010

Tryton initiates enrollment in Side Branch Stent System trial for coronary artery disease

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that the first patient has been enrolled in the pivotal trial to evaluate the Tryton Side Branch Stent System™ for the treatment of coronary artery disease.

20 Dec 2010

Congressional battle lines emerge over spending issues; Backers continue to press 9/11 health bill

On Capitol Hill, the lines are being drawn surrounding spending issues, and funding for the Obama administration's health law will be a flashpoint in the battle. Meanwhile, congressional backers of the 9/11 health bill continue to press ahead. And in action late on Sunday the Senate gives the nod to the food safety bill.

20 Dec 2010

Medical News

Biogen Idec acquires Neurimmune subsidiary

American Surgical to be acquired by AH Holdings

Treatment with acid-suppressive drugs associated with increased risk of pneumonia

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Echinacea may have minimal impact in relieving common cold

Study reveals nasal congestion can be a sign of severe asthma

PharMEDium introduces pre-labeled, ready-to-use Propofol in tamper evident syringe admixture system

New study finds racial, ethnic disparities in cancer treatment

Early life food influences life-long fertility

Wage growth slowed during economic downturn, report says

Hemispherx to manufacture and supply Alferon N Injection to GP Pharm in Argentina

Exome sequencing leads to correct diagnosis and life-saving treatment for mysterious genetic disorder

Robotic surgery as effective as other minimally invasive techniques for head and neck squamous cell carcinomas

Hutchinson Center's tips for weight loss in the new year

Veeva announces seamless integration of CRM solution with Mederi

Ambit commences Phase I advanced solid tumor trials for AC430 and AC480 inhibitors

Health-care coverage program for kids ends in Ariz.; Florida Medicaid patient information may be at risk

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

Tryton initiates enrollment in Side Branch Stent System trial for coronary artery disease

Congressional battle lines emerge over spending issues; Backers continue to press 9/11 health bill

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News